Icotinib Is an Active Treatment of Non-Small-Cell Lung Cancer: A Retrospective Study
Xiaofeng Chen(Ningbo University), Lingjun Zhu(Henan University), Kaihua Lu(Jiangsu Province Hospital), Jinghua Wang(Harbin Medical University), Renhua Guo(Sun Yat-sen University), Zhaoxia Wang(Shanghai Jiao Tong University), Ping Liu(Guiyang Medical University), Yongmei Yin(Jiangsu Cancer Hospital), Yongqian Shu(Jiangsu Province Hospital), Yiqian Liu(Jiangsu Province Hospital), Quan Zhu(Jiangsu Province Hospital), Yanhong Gu(Nanjing Medical University), Lianke Liu(Jiangsu Province Hospital), Oluf Dimitri Røe(Norwegian University of Science and Technology)
Cited by 28
Related Papers
LncRNA HOXA11-AS Promotes Proliferation and Invasion of Gastric Cancer by Scaffolding the Chromatin Modification Factors PRC2, LSD1, and DNMT1
|Cancer Research|2016|486
Long non-coding RNA MEG3 inhibits NSCLC cells proliferation and induces apoptosis by affecting p53 expression
|BMC Cancer|2013|436
Adebrelimab or placebo plus carboplatin and etoposide as first-line treatment for extensive-stage small-cell lung cancer (CAPSTONE-1): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
|The Lancet Oncology|2022|417
Camrelizumab Plus Carboplatin and Paclitaxel as First-Line Treatment for Advanced Squamous NSCLC (CameL-Sq): A Phase 3 Trial
|Journal of Thoracic Oncology|2021|311